Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Physical Examination × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Cancer Face 1

Interventions

Nivolumab 16 Ipilimumab 15 pembrolizumab 11 Cyclophosphamide 11 trametinib 9 Radiotherapy 8 dabrafenib 6 sargramostim 5 Interleukin-2 5 Fluorouracil 5 130-nm albumin-bound paclitaxel 5 aldesleukin 4 Vemurafenib 4 Radiosurgery 4 Peripheral Blood Stem Cell Transplantation 4 Melphalan 4 fludarabine phosphate 3 fludarabine 3 durvalumab 3 avelumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Cytarabine 3 Capecitabine 3 Biopsy 3 Bevacizumab 3 encorafenib 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03382704 2026-01-16

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

NHS Lothian

Skin Cancer Face

Data powered by HemOnc (CC BY 4.0) Colophon ⚡